Effects of Strength Exercise on Fall Risk in Elderly With Alzheimer's Disease
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 64
- Locations
- 2
- Primary Endpoint
- Change from baseline Short physical performance battery (SPPB) at 3 and 6 months
Study Overview
Brief Summary
Interventional study to show the effects of strength exercise on fall risk in elderly with Alzheimer's disease
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Eligibility Criteria
- Ages
- 60 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •accept to participate in the study, through informed consent
- •subjects aged 60 or over with medical diagnosis of Azlheimer´s disease
- •minimal physical and mental state to perform the cognitive tests and strength exercise routine
Exclusion Criteria
- •Neurodegenerative disease other than Alzheimer's disease
- •Suffering from serious somatic or psychiatric illnesses
- •Patients who have practiced strength exercise regularly
Arms & Interventions
Intervention group
This is the group that receives strength exercise in addition to usual treatment
Intervention: Strength exercise (Procedure)
Intervention group
This is the group that receives strength exercise in addition to usual treatment
Intervention: Usual treatment (Other)
Control group
This is the group that only receives usual treatment
Intervention: Usual treatment (Other)
Outcomes
Primary Outcomes
Change from baseline Short physical performance battery (SPPB) at 3 and 6 months
Time Frame: Baseline, 3 and 6 months (3 months after intervention)
Informs about fall risk and mobility Score: 0-12 High score means better result
Secondary Outcomes
- Change from baseline FRAIL test at 3 and 6 months(Baseline, 3 and 6 months (3 months after intervention))
- Change from baseline One Maximum repetition strength test (1 MR) at 1,2,3 and 6 months(Baseline, 1 , 2 , 3 and 6 months (3 months after intervention))
- Change from baseline Lawton Instrumental Activities of Daily Living Scale (IADL) at 3 and 6 months(Baseline, 3 and 6 months (3 months after intervention))
- Change from baseline Quality of life Alzheimer Disease (QoL-AD) at 3 and 6 months(Baseline, 3 and 6 months (3 months after intervention))
- Change from baseline Neuropsychiatric Inventory (NPI-Q) at 3 and 6 months(Baseline, 3 and 6 months (3 months after intervention))
- Change from baseline Mini Mental State Examination (MMSE) at 3 and 6 months(Baseline, 3 and 6 months (3 months after intervention))
- Change from baseline Activities specific balance confidence scale (ABC scale) at 3 and 6 months(Baseline, 3 and 6 months (3 months after intervention))
- Change from baseline Manual dynamometry at 1,2,3 and 6 months(Baseline, 1, 2, 3 and 6 months (3 months after intervention))
- Modified Borg scale(3 times/week during strength exercises sessions)
Investigators
Alexander Achalandabaso
Principal investigator
University of Jaén
